The use of Flash CGM in older people with type 2 diabetes receiving insulin treatment is possible regardless of social conditions or schooling, improving the glycemic profile and safety in conditions of high risk of hypoglycemia. The gene discussed is INS; the disease is type 2 diabetes mellitus.